For example, up to half of breast cancer patients selected for hormonal therapy based on positive ER staining do not respond, suggesting that ER expression does not necessarily imply an active ER pathway in cancer tissue [1, 2]. The gene discussed is ESR1; the disease is breast carcinoma.